183 related articles for article (PubMed ID: 22172441)
21. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity.
Reddy YNV; Rikhi A; Obokata M; Shah SJ; Lewis GD; AbouEzzedine OF; Dunlay S; McNulty S; Chakraborty H; Stevenson LW; Redfield MM; Borlaug BA
Eur J Heart Fail; 2020 Jun; 22(6):1009-1018. PubMed ID: 32150314
[TBL] [Abstract][Full Text] [Related]
22. Association Between Wearable Device Measured Activity and Patient-Reported Outcomes for Heart Failure.
Golbus JR; Gosch K; Birmingham MC; Butler J; Lingvay I; Lanfear DE; Abbate A; Kosiborod ML; Damaraju CV; Januzzi JL; Spertus J; Nallamothu BK
JACC Heart Fail; 2023 Nov; 11(11):1521-1530. PubMed ID: 37498273
[TBL] [Abstract][Full Text] [Related]
23. Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia.
Cooper TJ; Anker SD; Comin-Colet J; Filippatos G; Lainscak M; Lüscher TF; Mori C; Johnson P; Ponikowski P; Dickstein K
Am J Cardiol; 2016 May; 117(9):1482-7. PubMed ID: 27015889
[TBL] [Abstract][Full Text] [Related]
24. Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire.
Ravera A; Santema BT; Sama IE; Meyer S; Lombardi CM; Carubelli V; Ferreira JP; Lang CC; Dickstein K; Anker SD; Samani NJ; Zannad F; van Veldhuisen DJ; Teerlink JR; Metra M; Voors AA
Eur J Heart Fail; 2021 Apr; 23(4):567-577. PubMed ID: 33728762
[TBL] [Abstract][Full Text] [Related]
25. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure.
Rumsfeld JS; Havranek E; Masoudi FA; Peterson ED; Jones P; Tooley JF; Krumholz HM; Spertus JA;
J Am Coll Cardiol; 2003 Nov; 42(10):1811-7. PubMed ID: 14642693
[TBL] [Abstract][Full Text] [Related]
26. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
Armstrong PW; Lam CSP; Anstrom KJ; Ezekowitz J; Hernandez AF; O'Connor CM; Pieske B; Ponikowski P; Shah SJ; Solomon SD; Voors AA; She L; Vlajnic V; Carvalho F; Bamber L; Blaustein RO; Roessig L; Butler J;
JAMA; 2020 Oct; 324(15):1512-1521. PubMed ID: 33079152
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial.
Costanzo MR; Ivanhoe RJ; Kao A; Anand IS; Bank A; Boehmer J; Demarco T; Hergert CM; Holcomb RG; Maybaum S; Sun B; Vassiliades TA; Rayburn BK; Abraham WT
J Card Fail; 2012 Jun; 18(6):446-58. PubMed ID: 22633302
[TBL] [Abstract][Full Text] [Related]
28. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
Felker GM; Whellan D; Kraus WE; Clare R; Zannad F; Donahue M; Adams K; McKelvie R; Piña IL; O'Connor CM;
Am Heart J; 2009 Oct; 158(4 Suppl):S37-44. PubMed ID: 19782787
[TBL] [Abstract][Full Text] [Related]
29. Primary Results of the Patient-Centered Disease Management (PCDM) for Heart Failure Study: A Randomized Clinical Trial.
Bekelman DB; Plomondon ME; Carey EP; Sullivan MD; Nelson KM; Hattler B; McBryde CF; Lehmann KG; Gianola K; Heidenreich PA; Rumsfeld JS
JAMA Intern Med; 2015 May; 175(5):725-32. PubMed ID: 25822284
[TBL] [Abstract][Full Text] [Related]
30. Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]).
Gottlieb SS; Kop WJ; Ellis SJ; Binkley P; Howlett J; O'Connor C; Blumenthal JA; Fletcher G; Swank AM; Cooper L;
Am J Cardiol; 2009 May; 103(9):1285-9. PubMed ID: 19406273
[TBL] [Abstract][Full Text] [Related]
31. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.
Green CP; Porter CB; Bresnahan DR; Spertus JA
J Am Coll Cardiol; 2000 Apr; 35(5):1245-55. PubMed ID: 10758967
[TBL] [Abstract][Full Text] [Related]
32. The relationship between B-type natriuretic peptide and health status in patients with heart failure.
Luther SA; McCullough PA; Havranek EP; Rumsfeld JS; Jones PG; Heidenreich PA; Peterson ED; Rathore SS; Krumholz HM; Weintraub WS; Spertus JA; Masoudi FA;
J Card Fail; 2005 Aug; 11(6):414-21. PubMed ID: 16105631
[TBL] [Abstract][Full Text] [Related]
33. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.
Flynn KE; Piña IL; Whellan DJ; Lin L; Blumenthal JA; Ellis SJ; Fine LJ; Howlett JG; Keteyian SJ; Kitzman DW; Kraus WE; Miller NH; Schulman KA; Spertus JA; O'Connor CM; Weinfurt KP;
JAMA; 2009 Apr; 301(14):1451-9. PubMed ID: 19351942
[TBL] [Abstract][Full Text] [Related]
34. Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial.
Kerrigan DJ; Williams CT; Ehrman JK; Saval MA; Bronsteen K; Schairer JR; Swaffer M; Brawner CA; Lanfear DE; Selektor Y; Velez M; Tita C; Keteyian SJ
JACC Heart Fail; 2014 Dec; 2(6):653-9. PubMed ID: 25447348
[TBL] [Abstract][Full Text] [Related]
35. Burdensome Physical and Depressive Symptoms Predict Heart Failure-Specific Health Status Over One Year.
Lum HD; Carey EP; Fairclough D; Plomondon ME; Hutt E; Rumsfeld JS; Bekelman DB
J Pain Symptom Manage; 2016 Jun; 51(6):963-70. PubMed ID: 26921492
[TBL] [Abstract][Full Text] [Related]
36. Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction.
Piña IL; Camacho A; Ibrahim NE; Felker GM; Butler J; Maisel AS; Prescott MF; Williamson KM; Claggett BL; Desai AS; Solomon SD; Januzzi JL;
JACC Heart Fail; 2021 Jan; 9(1):42-51. PubMed ID: 33189630
[TBL] [Abstract][Full Text] [Related]
37. Variability in the clinical status of patients with advanced heart failure.
Hauptman PJ; Masoudi FA; Weintraub WS; Pina I; Jones PG; Spertus JA;
J Card Fail; 2004 Oct; 10(5):397-402. PubMed ID: 15470650
[TBL] [Abstract][Full Text] [Related]
38. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
[TBL] [Abstract][Full Text] [Related]
39. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.
Arnold SV; Li Z; Vemulapalli S; Baron SJ; Mack MJ; Kosinski AS; Reynolds MR; Hermiller JB; Rumsfeld JS; Cohen DJ
JAMA Cardiol; 2018 Dec; 3(12):1151-1159. PubMed ID: 30476950
[TBL] [Abstract][Full Text] [Related]
40. Assessing responsiveness of generic and specific health related quality of life measures in heart failure.
Eurich DT; Johnson JA; Reid KJ; Spertus JA
Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
